Heartbreaking
“Being told I had cancer was awful, but then to go through all of the treatment and surgery to then be told it was unnecessary was traumatising.
“And while I was delighted when I gave birth to Louis, it was really heartbreaking when I couldn’t breastfeed him.
“I am now worried about the possibility of actually developing cancer in the future because of the type of implants I have.
“I am also worried about complications that I may face because of my chemotherapy.
“While nothing will change what I’ve been through, I really need some answers on what is being done to make sure nobody else suffers in the same way I have.”
Sarah was just 25 when she was misdiagnosed by blundering doctors following the birth of Teddy.
She was later informed by her treating doctor that her biopsy had been incorrectly reported.
Sarah instructed specialist medical negligence lawyers who have now secured an admission of liability from University Hospitals of North Midlands NHS Trust.
Sarah Sharples, a legal expert at Irwin Mitchell Solicitors, who is representing Sarah, said: “This is a truly shocking case in which a young mother has faced heartbreaking news and a gruelling period of extensive treatment, only to be told that it was not necessary.
“The entire experience has had a huge impact on Sarah in many ways. While we welcome that the NHS Trust has admitted to the clear failings, we are yet to hear if any improvements have been put in place to prevent something like this happening again.
“We are also deeply concerned following reports surrounding the type of implants Sarah has, with suspicions over their potential link to a rare form of cancer. Understandably, Sarah has a number of questions that need to be answered with regards to this. It has caused her significant distress.” been for Sarah and her family. In addition to an unreserved apology to Sarah, the findings of the investigation have been shared with her and the case is now part of an ongoing legal claim with which the Trust is co-operating fully.
“Ultimately the misreporting of the biopsy was a human error so as an extra safeguard all invasive cancer diagnoses are now reviewed by a second pathologist.”